Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Zentralblatt Fur Chirurgie
|
December 20, 2017
Felix Nickel, Sven Lindner, Beat-Peter Müller-Stich
Science Signaling
|
October 30, 2014
ALK pERKs up MYCN in neuroblastoma
Sven Lindner, Anton Henssen, Kathy Astrahantseff, et al.
Cerebellum (London, England)
|
April 4, 2016
Overexpression of Lin28b in Neural Stem Cells is Insufficient for Brain Tumor Formation, but Induces Pathological Lobulation of the Developing Cerebellum
Annika K Wefers, Sven Lindner, Johannes H Schulte, et al.
Oncotarget
|
November 1, 2014
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells
Kristian W Pajtler, Ellen Mahlow, Andrea Odersky, et al.
Biomedical Reports
|
July 15, 2015
Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma
Sven Lindner, Hagen S Bachmann, Andrea Odersky, et al.
Science Signaling
|
April 30, 2015
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
Kristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Cancer Letters
|
January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma
Youjia Han, Sven Lindner, Yi Bei, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
International Journal of Cancer
|
July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
Kristina Althoff, Sven Lindner, Andrea Odersky, et al.
Oncotarget
|
December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
Kristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Zentralblatt Fur Chirurgie
|
December 20, 2017
Felix Nickel, Sven Lindner, Beat-Peter Müller-Stich
Science Signaling
|
October 30, 2014
ALK pERKs up MYCN in neuroblastoma
Sven Lindner, Anton Henssen, Kathy Astrahantseff, et al.
Cerebellum (London, England)
|
April 4, 2016
Overexpression of Lin28b in Neural Stem Cells is Insufficient for Brain Tumor Formation, but Induces Pathological Lobulation of the Developing Cerebellum
Annika K Wefers, Sven Lindner, Johannes H Schulte, et al.
Oncotarget
|
November 1, 2014
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells
Kristian W Pajtler, Ellen Mahlow, Andrea Odersky, et al.
Biomedical Reports
|
July 15, 2015
Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma
Sven Lindner, Hagen S Bachmann, Andrea Odersky, et al.
Science Signaling
|
April 30, 2015
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
Kristina B Emdal, Anna-Kathrine Pedersen, Dorte B Bekker-Jensen, et al.
Cancer Letters
|
January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma
Youjia Han, Sven Lindner, Yi Bei, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
International Journal of Cancer
|
July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
Kristina Althoff, Sven Lindner, Andrea Odersky, et al.
Oncotarget
|
December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
Kristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Page
of 2